Experience sampling for detection of early clinical changes during dose reduction of antipsychotics in patients with a psychotic disorder

Recruiting

Conditions: 10039628
psychosis
psychotic disorder

Registration Number: NL-OMON48652

Lead Sponsor: GGZ Eindhoven (Eindhoven)

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Not specified

Target Recruitment: 30

Inclusion Criteria

1. The participant has a diagnosis of a psychotic disorder.
2. Psychotic symptoms are in remission for at least three months for first
episode psychosis and at least six months for multiple episode psychosis.
3. Age 16-65 years.
4. The participant understands the study and is able to provide written
informed consent.
5. The participant is not participating in a medication study.
6. The participant is currently using antipsychotic medication and participant
and his/her treating clinician agree to discontinuation/dose reduction.
Patients with depot medication can also participate.
7. Sufficient command of the Dutch language.
8. Sufficient vision to read the questions in the PsyMate app and sufficient
hearing to hear the PsyMate signals.

Exclusion Criteria

Exclusion criteria are kept as few as possible. Only when the safety of the
participant is at risk, exclusion will follow.
Patients will be excluded from the trial if patients are not in remission (at
least 3 months for first episode patients and at least 6 months for multiple
episodes) .

Study & Design

Study Type: Observational non invasive

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Momentary mental states and behaviour in terms of psychotic experiences,<br /><br>subjective well-being (positive affect, negative affect, physical well-being),<br /><br>social interactions, sleep, cognition, dopamine super-sensitivity and negative<br /><br>symptoms in the context of daily life.</p><br>

Secondary Outcome Measures